PL4000615T3 - Podwójne antagonisty tnfr1 i agonisty tnfr2 do stosowania w chorobach nerek - Google Patents
Podwójne antagonisty tnfr1 i agonisty tnfr2 do stosowania w chorobach nerekInfo
- Publication number
- PL4000615T3 PL4000615T3 PL20207534.7T PL20207534T PL4000615T3 PL 4000615 T3 PL4000615 T3 PL 4000615T3 PL 20207534 T PL20207534 T PL 20207534T PL 4000615 T3 PL4000615 T3 PL 4000615T3
- Authority
- PL
- Poland
- Prior art keywords
- dual
- renal diseases
- tnfr2 agonists
- tnfr1 antagonists
- tnfr1
- Prior art date
Links
- 101100425758 Mus musculus Tnfrsf1b gene Proteins 0.000 title 1
- 101150009046 Tnfrsf1a gene Proteins 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 230000009977 dual effect Effects 0.000 title 1
- 208000017169 kidney disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20207534.7A EP4000615B1 (en) | 2020-11-13 | 2020-11-13 | Dual tnfr1 antagonists and tnfr2 agonists for use in renal diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4000615T3 true PL4000615T3 (pl) | 2022-12-19 |
Family
ID=73448924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20207534.7T PL4000615T3 (pl) | 2020-11-13 | 2020-11-13 | Podwójne antagonisty tnfr1 i agonisty tnfr2 do stosowania w chorobach nerek |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12083097B2 (pl) |
| EP (1) | EP4000615B1 (pl) |
| JP (1) | JP7462116B2 (pl) |
| CN (1) | CN116568296A (pl) |
| AU (1) | AU2021378077B2 (pl) |
| CA (1) | CA3197986A1 (pl) |
| ES (1) | ES2930093T3 (pl) |
| PL (1) | PL4000615T3 (pl) |
| WO (1) | WO2022101389A1 (pl) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1976509T3 (pl) | 2006-01-18 | 2015-07-31 | Evolva Sa | Modulatory PPAR |
| US8486994B2 (en) * | 2007-01-18 | 2013-07-16 | Evolva Sa | Prodrugs of substituted 1,3-dioxanes and their uses |
| EP2120567A4 (en) * | 2007-01-18 | 2011-11-09 | Evolva Sa | PRODRUGS OF SUBSTITUTED 1,3-DIOXANES AND THEIR USES |
| JP2016504994A (ja) * | 2012-12-18 | 2016-02-18 | エヴォルヴァ エスアー | 糖尿病患者における心血管リスクの治療 |
| WO2015193630A1 (en) * | 2014-06-18 | 2015-12-23 | Evolva Sa | Treatment of cardiovascular risk in patients with cardiovascular disease and/or diabetes |
| CN111825547B (zh) * | 2019-04-23 | 2022-04-19 | 南京海融医药科技股份有限公司 | 一种芳基丙酸类化合物的盐及其制药用途 |
-
2020
- 2020-11-13 PL PL20207534.7T patent/PL4000615T3/pl unknown
- 2020-11-13 ES ES20207534T patent/ES2930093T3/es active Active
- 2020-11-13 EP EP20207534.7A patent/EP4000615B1/en active Active
-
2021
- 2021-11-12 US US18/252,339 patent/US12083097B2/en active Active
- 2021-11-12 WO PCT/EP2021/081482 patent/WO2022101389A1/en not_active Ceased
- 2021-11-12 JP JP2023528450A patent/JP7462116B2/ja active Active
- 2021-11-12 AU AU2021378077A patent/AU2021378077B2/en active Active
- 2021-11-12 CN CN202180074898.5A patent/CN116568296A/zh active Pending
- 2021-11-12 CA CA3197986A patent/CA3197986A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2930093T3 (es) | 2022-12-07 |
| US20230414562A1 (en) | 2023-12-28 |
| WO2022101389A1 (en) | 2022-05-19 |
| AU2021378077B2 (en) | 2024-03-14 |
| EP4000615B1 (en) | 2022-10-19 |
| JP2023554588A (ja) | 2023-12-28 |
| CN116568296A (zh) | 2023-08-08 |
| CA3197986A1 (en) | 2022-05-19 |
| JP7462116B2 (ja) | 2024-04-04 |
| AU2021378077A1 (en) | 2023-05-25 |
| US12083097B2 (en) | 2024-09-10 |
| EP4000615A1 (en) | 2022-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI3806955T1 (sl) | Agonisti receptorja glp-1 in njihova uporaba | |
| IL200572A0 (en) | Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases | |
| ZA202206885B (en) | Anti-pd-1-anti-vegfa bispecific antibody, pharmaceutical composition and use thereof | |
| IL285289A (en) | Devices and methods for bodily fluid collection and distribution | |
| IL279015A (en) | Anti-interleukin-17A antibody, its pharmaceutical preparation and its use | |
| IL198829A0 (en) | Gm-csf antagonist use in treating chronic inflammatory diseases | |
| SG10202006451QA (en) | Managing transactions in multiple blockchain networks | |
| EP2948544A4 (en) | CHIMERIC RECEPTOR WITH NKG2D SPECIFICITY FOR CELL THERAPY AGAINST CANCER AND INFECTION DISEASES | |
| CL2013002869A1 (es) | Una combinacion que contiene 2-amino-n-[7-metoxi-8-(3-morfolin-4-ilpropoxi)-2,3-dihidroimidazo[1,2-c]quinazolin-5-il]pirimidin-5-carboxamida y abt-737; y su uso para el tratamiento o profilaxis de cancer de mama, en particular cáncer de mama inflamatorio, cancer de mama triple negativo, cancer de mama positivo a receptor de her2 y cancer de mama positivo a receptor de hormona. | |
| PL4025592T3 (pl) | Sprzężone mimetyki hepcydyny do stosowania w leczeniu czerwienicy prawdziwej | |
| EP3617224A4 (en) | SN 10 SELECTIVE ANTAGONIST OF TNFR1 AND ITS USE TO TREAT INFLAMMATORY DISEASE OF THE INTESTINE | |
| PL3806898T3 (pl) | Antagonista gremlin-1 do zastosowania w leczeniu nowotworu | |
| IL199045A0 (en) | Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases | |
| IL283104A (en) | Antagonistic cd40 monoclonal antibodies and uses thereof | |
| EP3062818A4 (en) | Bispecific antibodies that neutralize both tnf-alpha and il-6: novel therapeutic agent for autoimmune disease | |
| SG11201911599XA (en) | Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss | |
| IL277634A (en) | Leptin receptor agonist antibody for use in the treatment of metabolic dysfunction or hypoleptinemia | |
| SG11202010521VA (en) | Use of neutrophil elastase inhibitors in liver disease | |
| CL2011002416A1 (es) | Uso de un anticuerpo anti-il 17a y/o il-17f o fragmento que une antígeno del mismo que sirve en la preparación de un medicamento para el tratamiento de un trastorno de resistencia a insulina en un mamifero; kit. | |
| DOP2016000003A (es) | Formas de dosificación farmacéuticas estabilizadas que comprenden atrasentán | |
| SG11202101435XA (en) | ANTIBODY AGAINST IL-1ß, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| EP4054597A4 (en) | BLOOD PLASMA FRACTIONS FOR USE IN MUSCLE REGENERATION | |
| HRP20220346T3 (hr) | Antagonist glp-1 receptora za upotrebu u liječenju kongenitalnog hiperinzulinizma | |
| PL4000615T3 (pl) | Podwójne antagonisty tnfr1 i agonisty tnfr2 do stosowania w chorobach nerek | |
| TWI799398B (zh) | 供用於多層結構中之聚合物摻合物及包含所述聚合物摻合物之多層結構 |